Buyceps India Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 10-01-2025
- Paid Up Capital ₹ 1.01 Cr
as on 10-01-2025
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.20 Cr
as on 10-01-2025
- Revenue 208.99%
(FY 2021)
- Profit 104.11%
(FY 2021)
- Ebitda 176.20%
(FY 2021)
- Net Worth 191.41%
(FY 2021)
- Total Assets 76.29%
(FY 2021)
About Buyceps India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.01 Cr.
The company currently has active open charges totaling ₹1.20 Cr.
Vivek Yadav, Jagdish Kumar, and Vinod Kotha serve as directors at the Company.
- CIN/LLPIN
U51909MH2017PTC297623
- Company No.
297623
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2017
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Buyceps India Private Limited offer?
Buyceps India Private Limited offers a wide range of products and services, including Multivitamin Tablets & Capsules, Fertilizer, Amino Acids, Nutritional Supplements, L-Arginine Tablet, Nutraceuticals, Fitness Supplements, Amino Acid Supplements, Whey Protein, Muscletech Whey Protein.
Who are the key members and board of directors at Buyceps India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Yadav  | Managing Director | 20-Jul-2017 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinod Kotha | Additional Director | 29-Dec-2020 | Current |
| Jagdish Kumar | Director | 20-Jul-2017 | Current |
Financial Performance of Buyceps India.
Buyceps India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 208.99% increase. The company also saw a substantial improvement in profitability, with a 104.11% increase in profit. The company's net worth Soared by an impressive increase of 191.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Buyceps India?
In 2021, Buyceps India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Inwelco Science Private LimitedActive 2 years 6 monthsVivek Yadav, Jagdish Kumar and 1 more are mutual person
Charges (Loans)
₹1.20 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 1.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2021 | Others | ₹4.00 M | Open |
| 18 Jun 2021 | Others | ₹8.00 M | Open |
How Many Employees Work at Buyceps India?
Buyceps India has a workforce of 7 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Buyceps India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Buyceps India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
